These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 5899511)

  • 41. Systemic connective tissue diseases in India, VI. Raynaud's disease and pre-progressive systemic sclerosis (Pre-PSS).
    Malaviya AN; Narayanan K; Tiwari SC; Khan KM; Raina V; Pande JN
    J Assoc Physicians India; 1983 Oct; 31(10):625-8. PubMed ID: 6671930
    [No Abstract]   [Full Text] [Related]  

  • 42. [Scleroderma].
    Balabanova RM
    Feldsher Akush; 1980; 45(3):30-3. PubMed ID: 6899802
    [No Abstract]   [Full Text] [Related]  

  • 43. Stimulating circulation to end stasis in scleroderma.
    Yuan X; Li JD; Chen WJ; Li ZS; Zhu HT; Liu JW; Zhu MJ
    Chin Med J (Engl); 1981 Feb; 94(2):85-93. PubMed ID: 6786844
    [No Abstract]   [Full Text] [Related]  

  • 44. [A case of steroid tuberculosis in systemic scleroderma].
    Kazak TI; Teriaeva MV; Turintsev BB; Davlinskaia OI
    Probl Tuberk; 1996; (2):57-8. PubMed ID: 8657701
    [No Abstract]   [Full Text] [Related]  

  • 45. 65Zinc absorption in untreated and D-penicillamine-treated patients with generalized scleroderma: determination by whole-body counting technique.
    Høyer H; Hvid-Jacobsen K; Weismann K
    Acta Derm Venereol; 1982; 62(5):438-40. PubMed ID: 6183898
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative study on the antioxidant and biological activities of carvacrol, thymol, and eugenol derivatives.
    Mastelić J; Jerković I; Blazević I; Poljak-Blazi M; Borović S; Ivancić-Baće I; Smrecki V; Zarković N; Brcić-Kostic K; Vikić-Topić D; Müller N
    J Agric Food Chem; 2008 Jun; 56(11):3989-96. PubMed ID: 18473475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment of systemic scleroderma with fucidin].
    Rubisz-Brzezińska J; Zebracka T; Mozdzanowska K; Bendkowski W; Mozdzanowski J
    Przegl Dermatol; 1983; 70(2):209-15. PubMed ID: 6359277
    [No Abstract]   [Full Text] [Related]  

  • 48. Photochemotherapy for systemic and localized scleroderma.
    De Rie MA; Bos JD
    J Am Acad Dermatol; 2000 Oct; 43(4):725-6. PubMed ID: 11004642
    [No Abstract]   [Full Text] [Related]  

  • 49. [Trigeminal neuropathy in progressive systemic sclerosis. Letter].
    Campello I; Velilla J; Almárcegui C; Pérez López-Fraile I
    Rev Neurol; 1997 Jan; 25(137):137. PubMed ID: 9091199
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of scleroderma with depolymerizing agents].
    Konopík J; Krs V
    Cas Lek Cesk; 1982 Nov; 121(44):1368-72. PubMed ID: 7172189
    [No Abstract]   [Full Text] [Related]  

  • 51. Potassium para-aminobenzoate (Potaba) in scleroderma.
    Drug Ther Bull; 1968 Jun; 6(12):47-8. PubMed ID: 5657237
    [No Abstract]   [Full Text] [Related]  

  • 52. Cyclosporine in successful control of rapidly progressive scleroderma.
    Appelboom T; Itzkowitch D
    Am J Med; 1987 Apr; 82(4):866-7. PubMed ID: 3565449
    [No Abstract]   [Full Text] [Related]  

  • 53. [Relationship between progressive scleroderma and stomatology].
    Ivánkievicz D; Kovács Z
    Stoma (Heidelb); 1970 Aug; 23(3):156-62. PubMed ID: 5272529
    [No Abstract]   [Full Text] [Related]  

  • 54. [Thymol in the treatment of glaucoma].
    Truscă E; Filipescu I; Niculescu E
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1980; 24(3):225-8. PubMed ID: 6457348
    [No Abstract]   [Full Text] [Related]  

  • 55. Paronychia and onycholysis, etiology and therapy.
    Wilson JW
    Arch Dermatol; 1965 Dec; 92(6):726-30. PubMed ID: 5846329
    [No Abstract]   [Full Text] [Related]  

  • 56. [Progressive scleroderma cured by the oral and parenteral administration of paramethyl-isopropyl-phenol (thymol)].
    Buccellato G
    G Ital Dermatol Minerva Dermatol; 1965; 106(4):373-6. PubMed ID: 5899511
    [No Abstract]   [Full Text] [Related]  

  • 57. [Studies of the anti-HeLa phenomenon in the blood of subjects with skin neoplasms treated with paramethyl-isopropyl-phenol (thymol)].
    Buccellato G; Valguarnera G
    Boll Soc Ital Biol Sper; 1969 Mar; 45(6):343-5. PubMed ID: 5399627
    [No Abstract]   [Full Text] [Related]  

  • 58. [Inhibiting power of paramethyl-isopropyl-phenol (thymol) on the development of ascites tumor in the rat. Preliminary note].
    Buccellato G
    Boll Soc Ital Biol Sper; 1965 Jul; 41(14):757. PubMed ID: 5875916
    [No Abstract]   [Full Text] [Related]  

  • 59. Paramethyl-isopropyl-phenol (thymol) and caffeine in the treatment of skin neoplasms.
    Buccellato G
    G Ital Chemioter; 1975; 22(1-2):71-74. PubMed ID: 1235357
    [No Abstract]   [Full Text] [Related]  

  • 60. Natural remedies for scleroderma.
    Gaby AR
    Altern Med Rev; 2006 Sep; 11(3):188-95. PubMed ID: 17217320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.